{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:54:40Z","timestamp":1791212080410,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.bcmd.2009.01.012","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T05:23:35Z","timestamp":1236144215000},"page":"223-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Suppression of membrane microvesiculation \u2014 A possible anticoagulant and anti-tumor progression effect of heparin"],"prefix":"10.1016","volume":"42","author":[{"given":"Vid","family":"\u0160u\u0161tar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rado","family":"Jan\u0161a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Hagerstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Kr\u017ean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Igli\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kralj-Igli\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2009.01.012_bib1","first-page":"94","article-title":"Phlegmasia alba dolens","volume":"Vol. 3","author":"Trousseau","year":"1895"},{"key":"10.1016\/j.bcmd.2009.01.012_bib2","first-page":"364","article-title":"Trousseau's syndrome","volume":"158","author":"Callander","year":"1993","journal-title":"West J. Med."},{"key":"10.1016\/j.bcmd.2009.01.012_bib3","first-page":"437","article-title":"Cancer and venous thromboembolism: an overview","volume":"84","author":"Prandoni","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2009.01.012_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0149-2918(04)90038-0","article-title":"Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely ill medical inpatients in community practice","volume":"26","author":"McGarry","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcmd.2009.01.012_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jnci\/91.1.22","article-title":"Inhibition of metastases by anticoagulants","volume":"91","author":"Hejna","year":"1999","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.bcmd.2009.01.012_bib6","first-page":"59","article-title":"Heparin effects in metastasis and Trouseeau syndrome: anticoagulation is not the primary mechanism","volume":"1","author":"Stevenson","year":"2005","journal-title":"Haem. Rep."},{"key":"10.1016\/j.bcmd.2009.01.012_bib7","first-page":"48","article-title":"The use of heparin for treating human malignancies","volume":"29","author":"Ornstein","year":"1999","journal-title":"Haemostasis."},{"key":"10.1016\/j.bcmd.2009.01.012_bib8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1055\/s-0037-1614885","article-title":"The effects of unfractionated heparin on survival in patients with malignancy\u2014 a systematic review","volume":"82","author":"Smorenburg","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2009.01.012_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2000-9499","article-title":"Low-molecular-weight heparin and cancer","volume":"26","author":"Zacharski","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bcmd.2009.01.012_bib10","first-page":"1333","article-title":"Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?","volume":"16","author":"Deburdeau","year":"2008","journal-title":"Supp. Care Cancer"},{"key":"10.1016\/j.bcmd.2009.01.012_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S0100-879X2001000600003","article-title":"P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications","volume":"34","author":"Varki","year":"2001","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.bcmd.2009.01.012_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0897.1983.tb00204.x","article-title":"Membrane-associated immunoglobulins in cytsts and ascites fluids of ovarian cancer patients","volume":"3","author":"Taylor","year":"1983","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bcmd.2009.01.012_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0006-291X(83)91749-7","article-title":"Isolation of plasma membrane fragments from cultured murine melanoma cells","volume":"113","author":"Taylor","year":"1983","journal-title":"Biochem. Biophys. Res. Comun."},{"key":"10.1016\/j.bcmd.2009.01.012_bib14","first-page":"411","article-title":"Neoplastic and developmental importance of plasma membrane vesicles","volume":"26","author":"Taylor","year":"1987","journal-title":"Am. Zool."},{"key":"10.1016\/j.bcmd.2009.01.012_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.2910410425","article-title":"Characterization of plasma membrane shedding from murine melanoma cells","volume":"41","author":"Taylor","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2009.01.012_bib16","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/art.21350","article-title":"Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcmd.2009.01.012_bib17","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2004-03-1095","article-title":"Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation","volume":"106","author":"Del Conde","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2009.01.012_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1096\/fj.02-0574fje","article-title":"Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets","volume":"17","author":"Muller","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bcmd.2009.01.012_bib19","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1189\/jlb.0405193","article-title":"Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development","volume":"78","author":"Gross","year":"2005","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.bcmd.2009.01.012_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1160\/TH03-07-0487","article-title":"Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome","volume":"91","author":"Dignat-George","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2009.01.012_bib21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.leu.2404296","article-title":"Membrane-derived microvesicles: important and underappreciated mediators of cell to cell communication","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2009.01.012_bib22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1161\/01.CIR.0000036596.59665.C6","article-title":"Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus","volume":"106","author":"Diamant","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2009.01.012_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2006.03.001","article-title":"Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with \u03b22-glycoprotein-I and anti-\u03b22-glycoprotein-I antibodies","volume":"6","author":"Ambro\u017ei\u010d","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcmd.2009.01.012_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chemphyslip.2007.06.216","article-title":"Coalescence of phospholipid membranes as a possible origin of anticoagulant effect of serum proteins","volume":"150","author":"Urbanija","year":"2007","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bcmd.2009.01.012_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00249-007-0252-1","article-title":"Attachment of \u03b22-glycoprotein I to negatively charged liposomes may prevent the release of daughter vesicles from the parent membrane","volume":"37","author":"Urbanija","year":"2008","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bcmd.2009.01.012_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.autrev.2007.11.015","article-title":"Prevention of microvesiculation by adhesion of buds to the mother cell membrane \u2014 a possible anticoagulant effect of healthy donor plasma","volume":"7","author":"Frank","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcmd.2009.01.012_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcmd.2008.01.009","article-title":"Number of microvesicles in peripheral blood and ability of plasma to induce adhesion between phospholipid membranes in 19 patients with gastrointestinal diseases","volume":"41","author":"Jan\u0161a","year":"2008","journal-title":"Blood Cell. Mol. Dis."},{"key":"10.1016\/j.bcmd.2009.01.012_bib28","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1046\/j.1365-2141.1996.446981.x","article-title":"Beta 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant","volume":"93","author":"Brighton","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2009.01.012_bib29","doi-asserted-by":"crossref","DOI":"10.2478\/s11658-009-0018-0","article-title":"Cell to cell communication mechanisms by membranous nanostructures","volume":"14","author":"Schara","year":"2009","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bcmd.2009.01.012_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BFb0116295","article-title":"Preparation of giant vesicles by external AC electric fields. Kinetics and applications","volume":"89","author":"Angelova","year":"1992","journal-title":"Prog. Colloid and Polym. Sci."},{"key":"10.1016\/j.bcmd.2009.01.012_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2009.04745.x","article-title":"Effects of low molecular weight heparin on adhesion and vesiculation of phospholipid membranes. A possible mechanism for the treatment of hypercoagulability in antiphospholipid syndrome","author":"Frank","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2009.01.012_bib32","first-page":"16","article-title":"Selectins facilitate carcinom metastasis and heparin can prevent them","volume":"19","author":"Borsig","year":"2003","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.bcmd.2009.01.012_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02950396","article-title":"Cytological observations on carcinoma","volume":"391","author":"O'Meara","year":"1958","journal-title":"Irish J. Med. Sci."},{"key":"10.1016\/j.bcmd.2009.01.012_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/33.5.753","article-title":"Effect of inhibitors of fibrinolytic enzymes on development of pulmonary metastases","volume":"33","author":"Cliffton","year":"1964","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcmd.2009.01.012_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2004.04.001","article-title":"Heparin-induced cancer cell death","volume":"11","author":"Linhardt","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcmd.2009.01.012_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.chembiol.2004.03.023","article-title":"Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death","volume":"11","author":"Berry","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcmd.2009.01.012_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/07357900801935631","article-title":"The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro","volume":"26","author":"Chen","year":"2008","journal-title":"Cancer Inv."},{"key":"10.1016\/j.bcmd.2009.01.012_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcmd.2009.01.012_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1209\/epl\/i2004-10250-2","article-title":"Interaction between macroions mediated by divalent rod-like ions","volume":"68","author":"Bohinc","year":"2004","journal-title":"Europhys. Lett."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979609000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:26:23Z","timestamp":1761049583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979609000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1079979609000436"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.01.012","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of membrane microvesiculation \u2014 A possible anticoagulant and anti-tumor progression effect of heparin","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2009.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}